Recombinant Isfahan Virus Vectored Tri-Valent Vaccine to Protect against Western, Eastern, and Venezuelan Equine Encephalitis Virus

Project: Research project

Project Details

StatusFinished
Effective start/end date7/17/1511/30/17

Funding

  • Profectus BioSciences Incorporated: $1,359,075.00